Analgesic Efficacy Of Transdermal Buprenorphine For Postoperative Pain In Patients Undergoing Lumbar Discectomy
Phase 3
- Conditions
- Health Condition 1: M511- Thoracic, thoracolumbar and lumbosacral intervertebral disc disorders with radiculopathy
- Registration Number
- CTRI/2024/07/070061
- Lead Sponsor
- Sapthagiri Institute Of Medical Sciences And Research Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA grade I and II
Age 18-60yrs
Posted for lumbar discectomy
Exclusion Criteria
Patients not willing to participate in the study
Patients on any other form of opioid therapy for chronic pain
History of drug allergy or application
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare postoperative VAS score in patients receiving buprenorphine patch v/s control who wont receive buprenorphine patchTimepoint: VAS score , HR , BP , SPO2 will be assessed at 0, 2, 4, 8, 12, 24 and 48hrs in both the groups and recorded
- Secondary Outcome Measures
Name Time Method Time to first rescue analgesic. <br/ ><br>Total rescue analgesic. <br/ ><br>Timepoint: Time of first rescue analgesia, total analgesic consumption will be recorded in first 48 hours.